Cargando…
Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968878/ https://www.ncbi.nlm.nih.gov/pubmed/33605562 http://dx.doi.org/10.1002/cac2.12148 |
| _version_ | 1783666133122940928 |
|---|---|
| author | Young, Ken H. |
| author_facet | Young, Ken H. |
| author_sort | Young, Ken H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7968878 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79688782021-03-19 Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma? Young, Ken H. Cancer Commun (Lond) Research Highlight John Wiley and Sons Inc. 2021-02-19 /pmc/articles/PMC7968878/ /pubmed/33605562 http://dx.doi.org/10.1002/cac2.12148 Text en © 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Research Highlight Young, Ken H. Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma? |
| title | Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma? |
| title_full | Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma? |
| title_fullStr | Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma? |
| title_full_unstemmed | Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma? |
| title_short | Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma? |
| title_sort | intensive chemotherapy and sequential hematopoietic stem cell transplantation: is it necessary for high‐risk t‐cell lymphoblastic lymphoma? |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968878/ https://www.ncbi.nlm.nih.gov/pubmed/33605562 http://dx.doi.org/10.1002/cac2.12148 |
| work_keys_str_mv | AT youngkenh intensivechemotherapyandsequentialhematopoieticstemcelltransplantationisitnecessaryforhighrisktcelllymphoblasticlymphoma |